Perspectives in weight control in diabetes - SGLT2 inhibitors and GLP-1-glucagon dual agonism
{{output}}
Treatment of people with type 2 diabetes mellitus (T2D) and obesity should include glycemic control and sustained weight loss. However, organ protection and/or risk reduction for co-morbidities have also emerged as important goals. Here, we define this combine... ...